In our analysis, TTR appears to be an epiphenomenon of a more compromised clinical status at INS diagnosis, characterized by higher uricemia (possibly as a sign of more severe hypovolemia), higher proteinuria, or younger age. The gene discussed is TTR; the disease is Hypovolemia.